Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Clinical trial NCT01346293 · COMPLETED

Trial details

NCT number: NCT01346293
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Diphtheria Pertussis Measles Polio

Start date: 2011-04-01
Primary completion: 2013-05-01
Enrollment: 3372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.